SURMOUNT-2 Study Finds Individuals with Type 2 Diabetes and Obesity Lost an Average of 15% of their Body Weight when Taking Tirzepatide

/PRNewswire/ -- Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating...

Related Keywords

United States ,San Diego ,California ,Spain ,Spanish ,Americans ,American ,Facebook Asociaci ,Rebecca Fisher ,Instagram Amdiabetesassn ,W Timothy Garvey ,Facebook American Diabetes Association ,University Of Alabama At Birmingham ,Linkedin American Diabetes Association ,American Diabetes Association ,Diabetes Research Center ,University Professor ,Scientific Sessions Of The American Diabetes Association ,Once Weekly Drug ,Weight Loss ,Glycemic Control ,Scientific Sessions ,American Diabetes ,New Orleans ,New England Journal ,Potential Role ,Treating Obesity ,Spanish Facebook ,Americana De La Diabetes ,